or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    KYMR D Kymera Therapeutics, Inc. -1.23
    INAB D IN8bio, Inc. -0.47
    CLDI D Calidi Biotherapeutics, Inc. -6.11
    SLS D SELLAS Life Sciences Group, Inc. -1.61
    PSTX D Poseida Therapeutics, Inc. -0.37
    CASI D CASI Pharmaceuticals, Inc. -0.19
    MRKR D Marker Therapeutics, Inc. -7.18
    ARWR D Arrowhead Research Corporation -2.30
    MEIP D MEI Pharma, Inc. 0.36
    THAR D Tharimmune, Inc. 4.40
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Cancer Treatment Treatment Of Cancer Autoimmune Disease Biopharmaceutical Cancer Immunotherapy Immune System Immunology Oncology Ovarian Cancer Virotherapy Cell Therapy Hematologic Malignancies Hematological Malignancies Immunotherapies Leukemia Life Sciences

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 5.11
    CANC D Tema Oncology ETF 5.02
    MNTL D Tema Neuroscience and Mental Health ETF 4.48
    GNOM F Global X Genomics & Biotechnology ETF 4.31
    IBRN C iShares Neuroscience and Healthcare ETF 3.9
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CANC to GNOM Compare CANC to MNTL Compare MNTL to GNOM

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 18 THAR Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
        Nov 18 ARWR Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
        Nov 18 ARWR Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
        Nov 17 MRKR Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 CASI CASI Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
        Nov 17 MEIP Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
        Nov 16 SLS We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate
        Nov 15 CASI CASI Pharmaceuticals reports Q3 results
        Nov 15 CASI CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biopharmaceutical Cancer Immunotherapy Cell Therapy Biotechnology Immune System Lymphoma Medicine Tumor Acute Myeloid Leukemia Apoptosis Autoimmune Disease Cancer Treatment Cell Biology Clinical Medicine Immunotherapy Non Small Cell Lung Cancer Ovarian Cancer Treatment Of Cancer Virotherapy
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags